Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Recursion Pharmaceuticals, Inc. reported its Q2 2026 results, with revenue falling to US$7.67 million from US$19.22 million a ...

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated tar ...

Enterprise tech leaders need to stop betting on a specific model and build systems that work no matter who wins the AI race.

Against this backdrop, ArtArch recently announced the consolidation of its previously independent offerings—social creative ...

Economics is ultimately about production and distribution, and both are being reshaped by artificial intelligence. As AI advances rapidly, it is becoming ...

A Google DeepMind exec says the AI capex boom is a bet on recursive self-improvement, and admits today’s revenue cannot ...

Q2 2026 Earnings Call August 6, 2026 5:00 PM EDTCompany ParticipantsMarius BarnettDouglas Polinsky - Co-Founder, ...

Explore 25 bizarre and uncommon phobias that people actually have, from fear of ducks to long words. Uncover the strange ...

Key Points Interested in Sui Group Holdings Limited? Here are five stocks we like better. Second-quarter revenue and other ...

Discusses AI-Driven Service Optimization and Live Demonstration of Endurance System August 5, 2026 8:00 AM EDTCompany ...